Product Overview
This Tesamorelin + Ipamorelin combination product contains two GH secretagogue research peptides supplied together in a single kit by PeptaCo for qualified laboratory research. Tesamorelin is a 44-amino-acid GHRH analog, while Ipamorelin is a selective pentapeptide GHS-R agonist. The combination enables researchers to investigate complementary GH release pathways.
Key Product Details
- Product Name: Tesamorelin + Ipamorelin Combo
- Specification: 10mg total (5mg + 5mg per vial pair)
- Product Form: Lyophilized powder (2 separate vials per kit)
- Category: GH Secretagogue Research Peptides — Combination Kit
- Contents: Tesamorelin vial + Ipamorelin vial
Chemical Identity
Tesamorelin: 44-amino-acid GHRH analog (identical to native human GHRH). MW: ~5136 Da.
Ipamorelin: Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). MW: ~712 Da.
This combination kit provides matched vials for research into synergistic GH release mechanisms.
Research Context
The Tesamorelin + Ipamorelin combination is used in research settings to study synergistic GH release. Tesamorelin acts on GHRH receptors as a full-length analog, while Ipamorelin selectively targets GHS-R. PeptaCo supplies this combination kit for qualified laboratory research applications.
Storage and Handling
Store both vials in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.
Documentation and Quality
Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package. Each kit includes documentation for both components.
Important Notice
This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.
